To The Moon

$Rocket Lab USA, Inc.(RKLB)$ $AST SpaceMobile, Inc.(ASTS)$  $Tesla Motors(TSLA)$ Bullish

🎯 Executive Summary

I’m extremely confident, Rocket Lab has crossed the threshold from speculative launch operator to vertically integrated defence aligned space prime, and the market is temporarily mispricing the transition. Q4 revenue printed $180M versus $178M expected. EPS came in at -$0.09 versus -$0.10 expected. Non GAAP gross margin expanded to 44.3%. Backlog surged 73% YoY to $1.85B after adding $751M in Q4 alone, the largest quarterly increase in company history.

The stock fell -8.8% intraday and closed -4.89% as investors focused on the Neutron first launch shifting to Q4 2026. Yet the underlying operating engine delivered 21 successful Electron and HASTE launches in 2025 with a 100% success rate. The backlog now includes 49 contracted launches plus the $816M SDA Tracking Layer prime award, potentially scaling to ~$1B with subsystems.

This quarter marks a structural transition from “prove growth” to “prove margin durability while scaling defence programmes”. Peak R&D intensity is now behind them, with Neutron costs progressively shifting toward inventory build ahead of production cadence in 2026.

🐂 Bull Case

• Revenue Acceleration With Visibility

Q4 revenue $180M, +36% YoY. FY25 revenue $602M, +38% YoY. Q1 guide $185M to $200M versus Street $181M. Midpoint implies ~57% YoY growth. 37% of backlog expected to convert within 12 months.

• Margin Expansion And Operating Leverage

Non GAAP gross margin 44.3% in Q4 versus 38% GAAP. Non GAAP gross profit up 77% YoY to $79.6M. Electron cadence and higher mix of HASTE missions support ASP expansion.

• Record Backlog With Granularity

Backlog $1.85B, +73% YoY. 49 contracted launches embedded. ~74% Space Systems weighting (including $816M SDA prime anchoring multi-year revenue recognition weighted heavier in years two and three under ASC 606), ~26% Launch—de-risking growth from defense programs over pure cadence dependency.

• Fortress Liquidity

Cash and marketable securities $1.01B post $280.6M equity raise. Inventory $158.4M supporting backlog execution and Neutron build cycle.

• Defence Optionality Expanding

AFRL agreement for point to point cargo testing on Neutron broadens use case beyond launch. SDA missile tracking exposure increases strategic importance amid hypersonic demand growth.

🐻 Bear Case

• Neutron Timeline Slippage

First launch now Q4 2026 after Stage 1 tank rupture linked to third party manual layup defect. Prior guide was H2 2025 then Q1 2026. Further qualification risk remains during in house automated fibre placement transition.

• Near Term Margin Compression

Q1 non GAAP gross margin guide 39% to 41% versus 44.3% in Q4. Reflects early phase SDA mix and scaling costs.

• Persistent Cash Burn

FY25 operating cash flow negative $165.5M versus negative $48.9M prior year. Q4 GAAP operating loss $51M. R&D $78.8M, +63% YoY.

• EBITDA Still Negative

Q4 Adjusted EBITDA -$17.4M, improved from -$23.2M prior year. Q1 guide -$21M to -$27M, signalling continued investment phase.

• Dilution Risk

$280.6M raise strengthens balance sheet but increases share count. Extended Neutron delays could reintroduce capital markets dependency.

💰 Financial Performance Breakdown

Q4 Revenue $180M versus $178M expected. +36% YoY, +16% QoQ.

FY25 Revenue $602M, +38% YoY.

Q4 EPS -$0.09 versus -$0.10 expected.

GAAP Gross Margin 38%. Non GAAP Gross Margin 44.3%.

Non GAAP Gross Profit $79.6M, +77% YoY.

GAAP Operating Loss $51M.

R&D Expense $78.8M, +63% YoY.

Q4 Adjusted EBITDA -$17.4M.

Q1 Adjusted EBITDA guide -$21M to -$27M.

Backlog $1.85B, +73% YoY. $751M added in Q4.

37% expected conversion over next 12 months. Revenue weighted toward years two and three for large SDA programme.

Cash $1.01B. Inventory $158.4M supporting execution ramp.

🛠️ Strategic Headwinds And Execution Risk

The Neutron tank rupture was traced to third-party manual layup defect. Rocket Lab has shifted to fully in-house automated fiber placement, reducing dome layup time to days and compressing production cycles without incremental capex.

Management indicated peak R&D spend is now behind them, with programme costs pivoting toward inventory for subsequent builds and elevated capex on infrastructure (LC-3 Wallops, Middle River integration, Long Beach engines, Louisiana barge) to support Neutron ramp and SDA lead times. Qualification momentum continues ~ Hungry Hippo fairing delivered for integration, thrust structure qualified, interstage in qualification phase ~ prioritising reliability even if it means a few extra months. However, integrated hot fire and first flight validation remain key hurdles before revenue inflection. Initial margins on large primes may sit lower, creating interim volatility before fixed cost dilution and operating leverage materialize.

🧠 Analyst And Institutional Sentiment

Cantor Fitzgerald raised PT to $85 from $72, reiterates Overweight ~ staying bullish on record FY25 revenue ($602M), 21 successful launches, and >60% backlog growth, viewing the company as a disruptive prime in national security missions amid initiatives like Golden Dome.

Stifel raised PT to $90 from $85 despite the delay, citing backlog strength and execution consistency. Needham maintained Buy, adjusted PT to $95 reflecting timing shift. KeyBanc reiterates Sector Weight after Neutron launch delay to Q4 2026 (~6-month slip), seeing balanced near-term risk/reward.

Street PT range now approximately $85 to $95 (consensus tilting higher post-updates). Sentiment is constructive but recalibrated around delay headlines.

Post earnings options flow expanded with volatility repricing around the delay headline. Defence aligned fund flows remain supportive amid rising US budget allocations tied to missile tracking and hypersonic capability.

📉📈 Technical Setup After Earnings

The daily chart maintains a rising primary trendline from mid 2025. The post earnings gap lower tested the 80DMA demand band near $65 to $70. Price remains above structural horizontal support near $60.

RSI has cooled toward mid 50s from prior overbought levels. MACD momentum flattening but no confirmed structural breakdown.

Resistance sits near $85, then prior highs near $95.

Base target recovery $85. Stretch target $95 to $100 on confirmed volume expansion and margin stabilisation narrative.

🌍 Macro And Peer Context

Geopolitical fragmentation and rising defence budgets support sustained demand for missile tracking, hypersonic testing and sovereign launch capability. The SDA Tracking Layer programme aligns directly with these macro drivers.

Compared with early stage launch peers, Rocket Lab’s 44.3% non GAAP gross margin and $1.85B backlog represent superior commercial validation, albeit with similar investment phase cash burn dynamics.

📊 Valuation And Capital Health

With $1.01B liquidity and multi-year backlog visibility (37% converting next 12 months), the balance sheet provides real margin of safety during the extended Neutron phase and SDA scaling. FY25 net loss ~$198M (modest YoY increase) reflects investment intensity, but negative EBITDA/OCF trends should inflect as Neutron shifts to production and Space Systems margins expand. Valuation embeds successful Neutron execution and backlog conversion; operating leverage hinges on sustaining cadence beyond 2025's 21 missions while efficiently ramping the 49 contracted launches and defense programs.

⚖️ Verdict And Trade Plan

I remain bullish but disciplined. The Neutron delay is operationally significant yet financially absorbable under current liquidity. The core Electron and Space Systems businesses are demonstrably scaling.

Entry zone $65 to $70 near 80DMA demand.

Stop below $60 structural support.

Base target $85. Stretch target $95 to $100.

Confirmation requires volume expansion on reclaim of $75 and evidence of gross margin stabilisation within the 40% range next quarter.

Catalysts include Neutron hot fire milestones, AFRL cargo testing updates, SDA milestone revenue progression, LOXSAT mission execution, and next earnings.

🏁 Conclusion

I’m viewing this as a structurally strengthening defence aligned space platform temporarily repriced on execution timing rather than demand weakness. If Neutron validates on the revised schedule and backlog converts as modelled, the current volatility phase could ultimately mark the accumulation zone before the next expansion cycle.

📌 Key Takeaways

• Q4 revenue $180M, +36% YoY, beat by $2M

• Non GAAP gross margin 44.3%, Q1 guide 39% to 41%

• Backlog $1.85B, +73% YoY, 49 contracted launches

• Cash $1.01B, inventory $158.4M

• 21 launches in 2025, 100% success rate

• First Neutron launch now Q4 2026

📢 Don’t miss out! Like, Repost and Follow me for exclusive setups, cutting edge trends, and insights that move markets 🚀📈 I’m obsessed with hunting down the next big movers and sharing strategies that crush it. Let’s outsmart the market and stack those gains together! 🍀 Trade like a boss! Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀